The Vinogradov Laboratory

Department of Psychiatry, University of Minnesota



josh woolley danielle_0 gard Rachel Picture

                                            Vinogradov Research Lab

                                                      Department of Psychiatry, University of Minnesota


Joshua D. Woolley received his MD and PhD in neuroscience from the University of California at San Francisco (UCSF). Dr. Woolley's work has involved studying the mechanisms behind neurodegenerative and neuropsychiatric illnesses. Dr. Woolley is currently a psychiatrist and Assistant Professor at UCSF and the San Francisco VA Medical Center. Dr. Woolley's research interests involve examining the role of oxytocin as a potential biomarker for psychosis, its ability to affect dyadic family interactions, and its effectiveness in treating social cognitive deficits in adults and adolescents with neuropsychiatric disease.

Dr. Danielle Schlosser is an Assistant Professor and Clinical Psychologist in the Department of Psychiatry at UCSF. The focus of her research is on harnessing digital health strategies and the latest behavioral neuroscience of motivation to improve the lives of young people living with schizophrenia. Dr. Schlosser is the PI of an NIMH, Career Development Award, which is focused on developing an intervention strategy to robustly improve psychosocial and health functioning in recently diagnosed schizophrenia patients. The DRIVES lab also received two, UCSF CTSI grants and an NIH R34 grant to fund the development and feasibility testing of a mobile app called PRIME (Personalized, Real-time Intervention for Motivational Enhancement). The focus of PRIME is on harnessing the intact desire young people with schizophrenia have to improve their lives by giving them the necessary support and reinforcement to be successful. And while Daniellle is a researcher by day (and often nights!), she also enjoys spending as much time as possible in the outdoors, hiking, fishing, you name it.


Dr. Nahum is a senior scientist and Director of R&D at Posit Science. Her work centers on web-based interventions designed to improve social cognition in people with schizophrenia or autism spectrum disorders. She also studies the use of mobile technology to assess and change cognitive-emotional status. Dr. Nahum is a co-organizer of the Entertainment Software and Neurotherapeutics (ESCoNS) Conferences, bringing together neuroscientists and game developers to discuss ways in which we can harness game industry developments for neural and clinical therapeutics. She earned her PhD in Neural Computation at the Hebrew University of Jerusalem in Israel.

Dr. Loewy is a clinical psychologist and Assistant Professor in the UCSF Department of Psychiatry. She has been working in the area of early psychosis research for over 15 years. She is interested in identifying risk factors for psychosis, particularly those related to the experience of stress and trauma, and also works to implement evidence-based treatments for early psychosis into typical community practice through the Prevention and Recovery in Early Psychosis (PREP) programs.


David Gard received his Masters degree in clinical psychology from San Francisco State University in 1996 and his Ph.D. in clinical psychology from the University of California at Berkeley in 2005. He has been lecturing at San Francisco State University since 1997. His research interests are broadly in the area of emotion and motivation dysfunction in various disorders including schizophrenia and depression.